Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01688999
Title Cabozantinib for Advanced Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

ureter carcinoma

urethra cancer

bladder carcinoma

renal pelvis carcinoma

prostatic urethra urothelial carcinoma

Therapies

Cabozantinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.